1-Chloro-3-(difluoromethyl)-2-fluorobenzene, 98.0%, 5g

N-(2,4-Dinitrophenyl)-L-valine, 98%, 1g

2-(6-Aminopyridin-3-yl)acetic acid, 95.0%, 250mg

N-(3-Hydroxyphenyl)-4-methylbenzene-1-sulfonamide, 97%, 100mg

Fosfato de creatina sal disódica tetrahidr., mínimo 98 %, para bioquímica, 5 g

2-Amino-2-(1-methyl-1H-pyrazol-4-yl)acetic acid, 98%, 500mg

9H-XANTHEN-9-AMINE, 95.0%, 10g

4'-Ethylthio-2,2,2-trifluoroacetophenone, 97.0%, 1g

(S)-(+)-3-Aminopyrrolidine dihydrochloride, 97.0%, 5g

2-((3,4-DIHYDROISOQUINOLIN-1-YL)METHYL)ISOINDOLINE-1,3-DIONE, 95.0%, 500mg

Recipiente de cristalización ROTILABO® sin pico, 40 ml, 50 mm, 10 Unidad(es)

Ethyl 7-hydroxychroman-2-carboxylate, 95%, 250mg

(1-(Aminomethyl)cyclopentyl)methanol, 95.0%, 100mg